Exciting advance in curing cancer...!!The data had to be released without fanfare.
It's preliminary data about a probable cure for cancer. It can't be released with a "sales" or "promotional" tone.
And it presents a unique opportunity for those who understand Science! While those who were wanting "perfect"-results-or-nothing sell their shares, those of us who understand how this data points to Theralase's absolute dominance of the cancer treatment market can grow and solidify our positions.
With a 1/3 cure rate MINIMUM, this is the treatment everyone will want to try.
And that's a huge market, folks!
Hopefully, the learning curve for physicians will be gentle, because the less mistakes, the better success!
GLTA longs!